Terms ending in 2030
Rapid Pathogen Screening, Inc.
Every in-force patent on Rapid Pathogen Screening, Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,804,155 | Methods and Devices for Using Mucolytic Agents Including N-Acetyl Cysteine (NAC) In force · High confidence | Rapid Pathogen Screening, Inc. | In force | High confidence | |
| US 9,933,423 | Method and Device for Combined Detection of Viral and Bacterial Infections In force · High confidence | Rapid Pathogen Screening, Inc. | In force | High confidence | |
| US 10,379,121 | Method and Device for Combined Detection of Viral and Bacterial Infections In force · High confidence | Rapid Pathogen Screening, Inc. | In force | High confidence | |
| US 9,133,238 | Use of Peptides for Promoting Wound Healing In force · High confidence | Visus Therapeutics, Inc. | In force | High confidence | |
| US 10,408,835 | Method and Device for Combined Detection of Viral and Bacterial Infections In force · High confidence | Rapid Pathogen Screening, Inc. | In force | High confidence | |
| US 9,910,036 | Method and Device For Combined Detection Of Viral And Bacterial Infections In force · High confidence | Rapid Pathogen Screening, Inc. | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by Rapid Pathogen Screening, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.